Profound Medical Corp. (TSX:PRN)
8.22
-0.87 (-9.57%)
Apr 10, 2026, 3:59 PM EST
Profound Medical Revenue
In the year 2025, Profound Medical had annual revenue of $16.10M USD with 50.73% growth. Profound Medical had revenue of $5.98M in the quarter ending December 31, 2025, with 61.32% growth.
Revenue
$16.10M
Revenue Growth
+57.68%
P/S Ratio
13.50
Revenue / Employee
$99.37K
Employees
162
Market Cap
297.97M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.10M | 5.42M | 50.73% |
| Dec 31, 2024 | 10.68M | 3.48M | 48.35% |
| Dec 31, 2023 | 7.20M | 518.00K | 7.75% |
| Dec 31, 2022 | 6.68M | -192.00K | -2.79% |
| Dec 31, 2021 | 6.87M | -431.00K | -5.90% |
| Dec 31, 2020 | 7.30M | 3.13M | 74.99% |
| Dec 31, 2019 | 4.17M | 2.26M | 117.58% |
| Dec 31, 2018 | 1.92M | -1.98M | -50.81% |
| Dec 31, 2017 | 3.90M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 25.14M |
| Perimeter Medical Imaging AI | 3.16M |
| Cheelcare | 1.63M |
| Frequency Exchange | 1.12M |
| Theralase Technologies | 1.00M |
| Conavi Medical | 706.00K |
| MedX Health | 522.90K |
| Ventripoint Diagnostics | 175.62K |
Profound Medical News
- 2 days ago - Profound Medical Corp. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 10 days ago - Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting - GlobeNewsWire
- 15 days ago - Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone - GlobeNewsWire
- 22 days ago - Top 3 Health Care Stocks That Are Set To Fly In March - Benzinga
- 4 weeks ago - Profound Medical's (PROF) TULSA Procedure Shows Superior Safety Outcomes - GuruFocus
- 4 weeks ago - CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence - GlobeNewsWire
- 4 weeks ago - Profound Medical (PROF) Awaits Key Clinical Data Presentation - GuruFocus
- 5 weeks ago - Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - GuruFocus